$Codexis (CDXS.US)$$Pfizer (PFE.US)$ Pfizer disclosed purcha...

Pfizer disclosed purchase orders totaling $29 million.

Codexis said the orders are for the delivery of the company's enzyme products, which will be used in the production of Pfizer's Novel Coronavirus 19 drug candidate PF-07321332.

On June 17 and August 25, CDXS announced receipt of purchase orders for the production of unnamed active pharmaceutica intermediates in drug candidates.

In September, Pfizer announced the initiation of a Phase 2/3 clinical study to evaluate the efficacy of PF-07321332 in combination with low-dose ritonavir for the prevention of Novel Coronavirus-19.